- Despite more than doubling over the past twelve months, Sparton (SPA -0.4%) has more upside potential if a major contract with the U.S. Navy is secured, Barron's David Englander writes.
- Since 2011, SPA has boosted revenue 25% annually, and EBITDA 90% annually, as management focuses on buying up attractive manufacturing businesses in highly regulated markets such as defense and medical devices.